Session 1: Scientific Research and Lessons Learned Twenty Years after Chernobyl
Organizers: Geoffrey Howe, Columbia University, NY, and Ethel Gilbert, National Cancer Institute, MD

1. Thyroid Cancer-Elisabeth Cardis, International Agency for Research on Cancer, France
   
2. Leukemia-Geoffrey Howe, Columbia University, NY
   
3. Cataract Incidence-Norman Kleiman, Columbia University, NY
   
4. Autoimmune Thyroiditis-Alina Brenner, National Cancer Institute, MD
   
5. Dosimetry in Chernobyl Studies-Andre Bouville, National Cancer Institute, MD
   
6. Discussant: Norman Gentner, Past Secretary of UNSCEAR

Session 2: Low-dose Studies: Evidence from Exposures below ~100 mSv
Organizers: Amy Kronenberg, Lawrence Berkeley National Laboratory, CA; Mary Schubauer-Berigan, National Institute for Occupational Safety and Health, Washington, DC; and Bob Ullrich, Colorado State University, CO

1. Direct Evidence at Doses below ~100 mSv in the Atomic Bomb Survivor Studies-Dale Preston, Hirosoft, Inc., CA
   
2. Multi-site Case-control Study of Leukemia among Externally Exposed DOE Workers-Mary Schubauer-Berigan, National Institute for Occupational Safety and Health, OH
   
3. In Vitro Carcinogen Assays: Suppressive Effects at Low Doses-J. Leslie Redpath, University of California, Irvine, CA
   
4. H2AX Foci as a Sensitive Indicator of DNA Double-strand Breaks-Peggy Olive, BC Cancer Research Centre, Canada
   
5. Current Understanding of Bystander Effects at Low Doses—Tom Hei, Columbia University, NY
   
6. Discussant: Antone Brooks, Washington State University Tri-Cities, WA

Session 3: Cardiovascular and Cerebrovascular Outcomes and Radiation
Organizers: Sarah Darby, University of Oxford, UK, and Cecile Ronckers, National Cancer Institute, MD

1. Overview of Studies of Long-term Cardiovascular and Cerebrovascular Effects in Humans-Kiyohiko Mabuchi, National Cancer Institute, MD
   
2. Study of Long-term Cardiovascular Effects in Breast Cancer Patients-Sarah Darby, University of Oxford, UK
   
3. Studies of Short-term Cardiovascular Effects in Humans-Gabor Gyenes, University of Alberta, Canada
   
4. Radiation-induced Cardiovascular and Cerebrovascular Effects in Animal Studies-Fiona Stewart, The Netherlands Cancer Institute, The Netherlands
   
5. Discussant: Cecile Ronckers, National Cancer Institute, MD
   

Session 4: Radiation Studies in Russia and the Former Soviet Union
Organizers: Geoffrey Howe, Columbia University, NY, and Ethel Gilbert, National Cancer Institute, MD

1. Mayak Worker Mortality: Overview and Site-specific Risks-Natalia Shilnikova, Southern Urals Biophysics Institute, Russia
   
2. Mayak Worker Mortality: Risks of Lung, Liver, and Bone Cancer from Plutonium--Ethel Gilbert, National Cancer Institute, MD
   
3. Kazakhstan Thyroid Study-Charles Land, National Cancer Institute, MD
   
4. m-FISH Biodosimetry in Plutonium-exposed Workers-Rhona Anderson, Brunel University, UK
   
5. Discussant: Dale Preston, Hirosoft, Inc., CA

Session 5: Current Issues in Dosimetry
Organizers: Irene Jones, Lawrence Livermore National Laboratory, CA, and Daniel Stram, University of California, Los Angeles, CA

1. Overview and Innovative Analyses of Bio-dosimetry in the RERF Cohort-Harry Cullings, RERF, Japan
   
2. Using Molecular Signatures (RNA and Proteins) for Early Radiation Dosimetry-William F. Blakely, Armed Forces Radiobiology Research Institute, MD
   
3. Analysis of radiation dose response when detailed location of tumor and dose by location is known: Application to the WECARE Study of genetic susceptibility to radiation induced breast cancer-Bryan Langholz, University of Southern California, CA
   
4. Dosimetry Based on Treatment Plans for Radiotherapy-Carolyn Taylor, UK
   
5. Incorporation of Dose Uncertainties into Epidemiologic Analyses-Dan Stram, University of California, Los Angeles, CA
   
6. Discussant